CLL TFH express higher levels of TFH-associated activation markers PD-1 and ICOS than corresponding non-TFH CD4 T cells and more PD-1 than control TFH (Figure 1B). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.